Stefania De Luca

Title: Stefania De Luca: Innovator in Therapeutic Peptides

Introduction

Stefania De Luca is a prominent inventor based in Milan, Italy. She has made significant contributions to the field of therapeutic agents through her innovative research and development of cyclic and branched peptides. Her work focuses on the preparation and use of these peptides as diagnostic and therapeutic agents, particularly in the context of cancer treatment.

Latest Patents

Stefania De Luca holds 1 patent titled "Preparation and use of cyclic and branched peptides and their labelled derivatives as therapeutic agents, cholecystokinin agonists or antagonists, and diagnostic agents to identify and locate tumours." This patent application details the preparation of cyclic and branched peptides of general formula (I) and their conjugated derivatives labelled with a paramagnetic or radioactive metal. The compounds developed in this invention are utilized as diagnostic agents to identify and locate primary tumours and their metastases that over-express type A and/or B cholecystokinin receptors. Additionally, they serve as therapeutic agents and cholecystokinin agonists or antagonists.

Career Highlights

Stefania De Luca has established herself as a key figure in her field, working at Bracco Imaging S.p.A. Her expertise in peptide technology has positioned her as a leader in the development of innovative solutions for cancer diagnostics and treatment.

Collaborations

Throughout her career, Stefania has collaborated with notable colleagues, including Michele Saviano and Diego Tesauro. These partnerships have enhanced her research and contributed to the advancement of therapeutic peptide applications.

Conclusion

Stefania De Luca's work exemplifies the intersection of innovation and healthcare, particularly in the realm of cancer diagnostics and treatment. Her contributions through her patent and collaborations continue to impact the field positively.